Dr. Horst Schmidt Klinik GmbH
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Dual Tandem Study - SC vs. CAD-EYE vs. CAD-EYE With G-EYE
Role: lead
Comparison of Colonoscopy Adenoma Detection Yield
Role: lead
Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy
Role: lead
Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal
Role: lead
Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®
Role: lead
Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.
Role: lead
Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy
Role: lead
Cardioprotection by Sevoflurane Preconditioning in Noncardiac Thoracic Surgery
Role: lead
Gastrointestinal Bleeding Management
Role: lead
Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
Role: lead
Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.
Role: lead
Muscle Relaxation for Short Procedures
Role: lead
All 12 trials loaded